Michael Zhang is a Senior Analyst in Strategic Finance at Roivant Sciences since July 2022, focusing on maximizing the value of the Vant portfolio through partnerships, mergers and acquisitions, and non-dilutive financing. Prior experience includes a Purification Development Internship at Genentech, where Michael developed a relational database framework and automated data aggregation for modeling, and a Principal Engineer role at Cornell University, collaborating with Weill Cornell physicians on a low-cost laryngoscope project for Zimbabwe. Michael's academic background includes a Master of Engineering and a Bachelor's degree in Biomedical/Medical Engineering and Biological/Biosystems Engineering, respectively, from Cornell University, alongside various teaching and research assistantships in medical technologies and biochemistry.
This person is not in any teams
This person is not in any offices